cDNA - Geunim – Law Together

Myriad Genetics: The US Law on Human Gene Patenting

Discover the pivotal US Supreme Court decision on gene patents, Association for Molecular Pathology v. Myriad Genetics, Inc., and understand the difference between patent-eligible synthetic DNA (cDNA) and unpatentable natural DNA segments. This guide is essential for researchers, biotechnology professionals, and anyone interested in intellectual property law’s impact on genetic science. For decades, the intersection […]

" even when isolated, 2013, applications, BRCA1, BRCA2, cDNA, diagnostic processes, Diagnostic Tests, DNA Sequencing, Gene Patent, genetic testing, innovation, is subject to change, Isolated DNA, machine, manufacture, Myriad Genetics, natural phenomena, new applications, non-obviousness, Patent Act, Patent Eligibility, Product of Nature, Supreme Court